We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
FormFactor
FORM
$8.11B
| $3.83M | ﹤0.01% |
+68,653
| New | +$3.46M |
|
|
URG
1252
Ur-Energy
URG
$485M
| $3.82M | ﹤0.01% |
+2,747,167
| New | +$4.07M |
|
1253
Cognex
CGNX
$10.3B
| $3.82M | ﹤0.01% |
106,038
-245,588
| -70% | -$9.94M |
|
1254
Context Therapeutics
CNTX
$56.4M
| $3.81M | ﹤0.01% |
2,593,198
+2,557,448
| +7,154% | +$2.99M |
|
1255
Universal Insurance Holdings
UVE
$1.16B
| $3.81M | ﹤0.01% |
112,749
-18,478
| -14% | -$589K |
|
|
FRGE
1256
DELISTED
Forge Global Holdings
FRGE
| $3.8M | ﹤0.01% |
85,316
+12,223
| +17% | +$413K |
|
1257
nVent Electric
NVT
$24.5B
| $3.8M | ﹤0.01% |
+37,276
| New | +$3.87M |
|
1258
Bank OZK
OZK
$5.49B
| $3.8M | ﹤0.01% |
82,574
-6,043
| -7% | -$283K |
|
1259
Helios Technologies
HLIO
$2.64B
| $3.79M | ﹤0.01% |
70,831
+8,548
| +14% | +$461K |
|
|
CCC
1260
CCC Intelligent Solutions
CCC
$3.42B
| $3.79M | ﹤0.01% |
476,488
-1,656,420
| -78% | -$13.5M |
|
|
LIF
1261
Life360
LIF
$3.96B
| $3.78M | ﹤0.01% |
58,932
-341,563
| -85% | -$28.4M |
|
1262
Birkenstock
BIRK
$7.47B
| $3.78M | ﹤0.01% |
92,369
+46,151
| +100% | +$1.95M |
|
1263
Rithm Capital
RITM
$5.09B
| $3.76M | ﹤0.01% |
344,552
-708,835
| -67% | -$7.83M |
|
1264
Compass Diversified
CODI
$755M
| $3.75M | ﹤0.01% |
780,482
+744,063
| +2,043% | +$4.7M |
|
1265
Arhaus
ARHS
$1.12B
| $3.72M | ﹤0.01% |
+332,275
| New | +$3.45M |
|
1266
TETRA Technologies
TTI
$1.23B
| $3.72M | ﹤0.01% |
396,897
-411,755
| -51% | -$3.18M |
|
|
OPRA
1267
Opera Ltd
OPRA
$1.65B
| $3.69M | ﹤0.01% |
260,468
-391,497
| -60% | -$5.77M |
|
1268
Under Armour Class C
UA
$2.92B
| $3.68M | ﹤0.01% |
+767,643
| New | +$3.41M |
|
1269
American Express
AXP
$223B
| $3.68M | ﹤0.01% |
9,954
+3,954
| +66% | +$1.41M |
|
|
WLTH
1270
Wealthfront Corp
WLTH
$1.33B
| $3.68M | ﹤0.01% |
+270,910
| New | +$3.6M |
|
1271
AngioDynamics
ANGO
$562M
| $3.66M | ﹤0.01% |
284,688
-53,459
| -16% | -$660K |
|
1272
Nelnet
NNI
$4.79B
| $3.65M | ﹤0.01% |
27,471
-23,192
| -46% | -$3.03M |
|
|
ALMS
1273
Alumis Inc
ALMS
$3.57B
| $3.64M | ﹤0.01% |
+372,901
| New | +$2.6M |
|
1274
Sweetgreen
SG
$713M
| $3.64M | ﹤0.01% |
538,145
-3,385,828
| -86% | -$23.3M |
|
1275
Alkermes
ALKS
$8.82B
| $3.63M | ﹤0.01% |
+129,899
| New | +$3.89M |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.